Landmark Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$334K Sell
2,542
-20
-0.8% -$2.32K 0.08% 71
2019
Q3
$287K Buy
2,562
+33
+1% +$3.67K 0.18% 75
2019
Q2
$281K Sell
2,529
-143
-5% -$16.8K 0.18% 76
2019
Q1
$347K Sell
2,672
-1,172
-30% -$143K 0.24% 63
2018
Q4
$445K Sell
3,844
-599
-13% -$66.9K 0.33% 52
2018
Q3
$477K Sell
4,443
-307
-6% -$30.7K 0.29% 53
2018
Q2
$405K Buy
+4,750
New +$390K 0.26% 53

Other funds holding LLY

Landmark Bank's LLY Position: Q4 2019 in Review

Landmark Bank reduced its Eli Lilly (LLY) stake by 0.78% in Q4 2019, selling an estimated $2.32K and leaving 2,542 shares worth $334K. The position accounts for 0.08% of the portfolio, ranked #71.

Landmark Bank first reported a position in LLY in Q2 2018 and has held it in 7 quarters since. The position peaked at $477K in Q3 2018. 1,672 funds tracked by Wall St. Rank hold LLY as of Q4 2019.

  • Landmark Bank held 2,542 shares of Eli Lilly worth $334K as of Q4 2019.
  • Landmark Bank sold 20 Eli Lilly shares in Q4 2019, an estimated $2.32K.
  • Eli Lilly made up 0.08% of Landmark Bank's portfolio in Q4 2019, its #71 holding.
  • Landmark Bank first reported a position in Eli Lilly in Q2 2018 and has held it in 7 quarters since.
  • Landmark Bank's Eli Lilly position peaked at $477K in Q3 2018.
  • 1,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2019.

Based on Landmark Bank's 13F filing for Q4 2019, filed 12 Feb 2020.